Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | SWTX | KROS | ||
| Company | Ra Pharmaceuticals Inc | Springworks Therapeutics Inc | Keros Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 30.11 | 58.50 | ||
| High | 48.01 | 30.68 | 60.14 | ||
| Low | 47.98 | 29.73 | 58.14 | ||
| Last | 48.00 | 30.62 | 59.94 | ||
| Change | -0.02 | +0.49 | +1.90 | ||
| % Change | -0.03% | +1.63% | +3.27% | ||
| Volume | 3,864,600 | 481,100 | 351,400 | ||
| 20-Day Average Volume | 1,869,975 | 859,590 | 297,320 | ||
| Previous Close | 48.01 | 30.13 | 58.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 30.40 | 59.86 | ||
| 20-Day Raw Stochastic | 99.68% | 40.23% | 53.48% | ||
| 20-Day Relative Strength | 56.47% | 42.67% | 55.54% | ||
| Weighted Alpha | +21.70 | -11.03 | +72.10 | ||
| Today's Opinion | 56% Buy | 88% Sell | 80% Buy | ||
| Previous Opinion | 56% Buy | 100% Sell | 64% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +4.47% since 10/25/24 | -1.35% since 10/25/24 | ||
| Low | 46.34 on 03/26/20 | 29.25 on 10/29/24 | 57.79 on 10/31/24 | ||
| High | 48.02 on 03/31/20 | 31.18 on 10/31/24 | 62.68 on 10/28/24 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -4.97% since 10/01/24 | +0.25% since 10/01/24 | ||
| Low | 40.30 on 03/18/20 | 28.21 on 10/24/24 | 56.79 on 10/10/24 | ||
| High | 48.02 on 03/31/20 | 34.20 on 10/08/24 | 62.68 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -13.16% since 08/01/24 | +19.02% since 08/01/24 | ||
| Low | 40.30 on 03/18/20 | 28.21 on 10/24/24 | 42.83 on 08/08/24 | ||
| High | 48.02 on 03/31/20 | 43.64 on 08/26/24 | 62.68 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | -34.63% since 05/01/24 | +3.85% since 05/01/24 | ||
| Low | 22.25 on 10/08/19 | 28.21 on 10/24/24 | 40.93 on 07/09/24 | ||
| High | 48.02 on 03/31/20 | 47.62 on 05/02/24 | 62.68 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,274,240 | 2,249,068 | ||
| Shares Outstanding, K | 47,329 | 74,273 | 37,522 | ||
| Annual Sales | 3,000,000 | 5,450,000 | 150,000 | ||
| Annual Net Income | -102,690,000 | -325,100,000 | -152,990,000 | ||
| Last Quarter Sales | 3,000,000 | 59,730,000 | 40,000 | ||
| Last Quarter Net Income | -24,980,000 | -39,920,000 | -45,260,000 | ||
| 60-Month Beta | 1.04 | 0.79 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.54 on 08/07/24 | -1.25 on 08/07/24 | ||
| Latest Earnings Date | 05/14/20 | 11/12/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||